[Pharmacotherapy of epilepsy. II].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D008617:Mephenytoin / Q000627:therapeutic use; D008618:Mephobarbital / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D013388:Succinimides / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000927:Anticonvulsants; D013388:Succinimides; D013843:Thiazines; D001569:Benzodiazepines; D011324:Primidone; D002220:Carbamazepine; D008618:Mephobarbital; D014635:Valproic Acid; D010672:Phenytoin; D000324:Adrenocorticotropic Hormone; D008617:Mephenytoin; D010634:Phenobarbital
Zur Pharmakotherapie der Epilepsien (II).